217 related articles for article (PubMed ID: 33400522)
1. Unexpected Trends in Copper Removal from Aβ Peptide: When Less Ligand Is Better and Zn Helps.
Esmieu C; Balderrama-Martínez-Sotomayor R; Conte-Daban A; Iranzo O; Hureau C
Inorg Chem; 2021 Jan; 60(2):1248-1256. PubMed ID: 33400522
[TBL] [Abstract][Full Text] [Related]
2. Mutual interference of Cu and Zn ions in Alzheimer's disease: perspectives at the molecular level.
Atrián-Blasco E; Conte-Daban A; Hureau C
Dalton Trans; 2017 Oct; 46(38):12750-12759. PubMed ID: 28937157
[TBL] [Abstract][Full Text] [Related]
3. Metal ions and intrinsically disordered proteins and peptides: from Cu/Zn amyloid-β to general principles.
Faller P; Hureau C; La Penna G
Acc Chem Res; 2014 Aug; 47(8):2252-9. PubMed ID: 24871565
[TBL] [Abstract][Full Text] [Related]
4. Hybrid Bis-Histidine Phenanthroline-Based Ligands to Lessen Aβ-Bound Cu ROS Production: An Illustration of Cu(I) Significance.
Drommi M; Rulmont C; Esmieu C; Hureau C
Molecules; 2021 Dec; 26(24):. PubMed ID: 34946712
[TBL] [Abstract][Full Text] [Related]
5. Rationally Designed Cu(I) Ligand to Prevent CuAβ-Generated ROS Production in the Alzheimer's Disease Context.
Rulmont C; Stigliani JL; Hureau C; Esmieu C
Inorg Chem; 2024 Feb; 63(5):2340-2351. PubMed ID: 38243896
[TBL] [Abstract][Full Text] [Related]
6. How Zn can impede Cu detoxification by chelating agents in Alzheimer's disease: a proof-of-concept study.
Conte-Daban A; Day A; Faller P; Hureau C
Dalton Trans; 2016 Oct; 45(39):15671-15678. PubMed ID: 27711738
[TBL] [Abstract][Full Text] [Related]
7. Cu and Zn interactions with Aβ peptides: consequence of coordination on aggregation and formation of neurotoxic soluble Aβ oligomers.
Rana M; Sharma AK
Metallomics; 2019 Jan; 11(1):64-84. PubMed ID: 30234208
[TBL] [Abstract][Full Text] [Related]
8. Ability of Azathiacyclen Ligands To Stop Cu(Aβ)-Induced Production of Reactive Oxygen Species: [3N1S] Is the Right Donor Set.
Malikidogo KP; Drommi M; Atrián-Blasco E; Hormann J; Kulak N; Esmieu C; Hureau C
Chemistry; 2023 Mar; 29(14):e202203667. PubMed ID: 36606721
[TBL] [Abstract][Full Text] [Related]
9. Why the Ala-His-His Peptide Is an Appropriate Scaffold to Remove and Redox Silence Copper Ions from the Alzheimer's-Related Aβ Peptide.
Gonzalez P; Sabater L; Mathieu E; Faller P; Hureau C
Biomolecules; 2022 Sep; 12(10):. PubMed ID: 36291536
[TBL] [Abstract][Full Text] [Related]
10. Zn impacts Cu coordination to amyloid-β, the Alzheimer's peptide, but not the ROS production and the associated cell toxicity.
Alies B; Sasaki I; Proux O; Sayen S; Guillon E; Faller P; Hureau C
Chem Commun (Camb); 2013 Feb; 49(12):1214-6. PubMed ID: 23282470
[TBL] [Abstract][Full Text] [Related]
11. Copper reduction and dioxygen activation in Cu-amyloid beta peptide complexes: insight from molecular modelling.
Arrigoni F; Prosdocimi T; Mollica L; De Gioia L; Zampella G; Bertini L
Metallomics; 2018 Nov; 10(11):1618-1630. PubMed ID: 30345437
[TBL] [Abstract][Full Text] [Related]
12. Insights into the oxygen-based ligand of the low pH component of the Cu(2+)-amyloid-β complex.
Gomez-Castro CZ; Vela A; Quintanar L; Grande-Aztatzi R; Mineva T; Goursot A
J Phys Chem B; 2014 Aug; 118(34):10052-64. PubMed ID: 25090035
[TBL] [Abstract][Full Text] [Related]
13. Modeling copper binding to the amyloid-β peptide at different pH: toward a molecular mechanism for Cu reduction.
Furlan S; Hureau C; Faller P; La Penna G
J Phys Chem B; 2012 Oct; 116(39):11899-910. PubMed ID: 22974015
[TBL] [Abstract][Full Text] [Related]
14. A Trishistidine Pseudopeptide with Ability to Remove Both Cu
Conte-Daban A; Boff B; Candido Matias A; Aparicio CNM; Gateau C; Lebrun C; Cerchiaro G; Kieffer I; Sayen S; Guillon E; Delangle P; Hureau C
Chemistry; 2017 Dec; 23(67):17078-17088. PubMed ID: 28846165
[TBL] [Abstract][Full Text] [Related]
15. pH-dependence of the specific binding of Cu(II) and Zn(II) ions to the amyloid-β peptide.
Ghalebani L; Wahlström A; Danielsson J; Wärmländer SK; Gräslund A
Biochem Biophys Res Commun; 2012 May; 421(3):554-60. PubMed ID: 22525674
[TBL] [Abstract][Full Text] [Related]
16. Reaction rates and mechanism of the ascorbic acid oxidation by molecular oxygen facilitated by Cu(II)-containing amyloid-beta complexes and aggregates.
Jiang D; Li X; Liu L; Yagnik GB; Zhou F
J Phys Chem B; 2010 Apr; 114(14):4896-903. PubMed ID: 20302320
[TBL] [Abstract][Full Text] [Related]
17. Methionine does not reduce Cu(II)-beta-amyloid!--rectification of the roles of methionine-35 and reducing agents in metal-centered oxidation chemistry of Cu(II)-beta-amyloid.
da Silva GF; Lykourinou V; Angerhofer A; Ming LJ
Biochim Biophys Acta; 2009 Jan; 1792(1):49-55. PubMed ID: 19061952
[TBL] [Abstract][Full Text] [Related]
18. Identifying, by first-principles simulations, Cu[amyloid-β] species making Fenton-type reactions in Alzheimer's disease.
La Penna G; Hureau C; Andreussi O; Faller P
J Phys Chem B; 2013 Dec; 117(51):16455-67. PubMed ID: 24313818
[TBL] [Abstract][Full Text] [Related]
19. Copper-Targeting Approaches in Alzheimer's Disease: How To Improve the Fallouts Obtained from in Vitro Studies.
Esmieu C; Guettas D; Conte-Daban A; Sabater L; Faller P; Hureau C
Inorg Chem; 2019 Oct; 58(20):13509-13527. PubMed ID: 31247877
[TBL] [Abstract][Full Text] [Related]
20. Specific Binding of Cu(II) Ions to Amyloid-Beta Peptides Bound to Aggregation-Inhibiting Molecules or SDS Micelles Creates Complexes that Generate Radical Oxygen Species.
Tiiman A; Luo J; Wallin C; Olsson L; Lindgren J; Jarvet J; Per R; Sholts SB; Rahimipour S; Abrahams JP; Karlström AE; Gräslund A; Wärmländer SK
J Alzheimers Dis; 2016 Oct; 54(3):971-982. PubMed ID: 27567855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
